These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14444542)

  • 1. Blood lipid variations in patients with hypercholesterolaemia and coronary artery disease. Part I.
    SEGALL S; NEUFELD AH
    Can Med Assoc J; 1960 Sep; 83(10):521-4. PubMed ID: 14444542
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of estrogens on the plasma lipids in coronary artery disease.
    OLIVER MF; BOYD GS
    Am Heart J; 1954 Mar; 47(3):348-59. PubMed ID: 13124250
    [No Abstract]   [Full Text] [Related]  

  • 3. Total serum cholesterol, cholesterol-lipid phosphorus ratio, and Sf 12-20 concentration in hypertension, diabetes, and coronary artery disease.
    KATZ LB; RHODES GJ; GEORGE RS; MOSES C
    Am J Med Sci; 1953 Feb; 225(2):120-8. PubMed ID: 13016551
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum phospholipids in coronary artery disease.
    COHEN L
    J Lab Clin Med; 1959 Sep; 54():352-6. PubMed ID: 13810973
    [No Abstract]   [Full Text] [Related]  

  • 5. The fatty acids of the blood in coronary-artery disease.
    JAMES AT; LOVELOCK JE; WEBB J; TROTTER WR
    Lancet; 1957 Apr; 272(6971):705-8. PubMed ID: 13417571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypercholesterolemia and arterial pathology. II. Its interest for the prognosis and prevention of coronary thrombosis].
    POUMAILLOUX M; TETREAU H
    Arch Mal Coeur Vaiss; 1952 Jul; 45(7):596-610. PubMed ID: 12987032
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum lipid patterns in coronary artery disease.
    Arora OP; Dhanda PC
    J Assoc Physicians India; 1968 Nov; 16(11):863-8. PubMed ID: 5713491
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of trilodothyroacetic acid on serum cholesterol and phospholipids in patients with coronary artery diseases.
    CHURCH G; LAWRIE TD; PIRRIE R
    Scott Med J; 1957 Jul; 2(7):293-8. PubMed ID: 13454834
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of triparanol (MER-29) in subjects with and without coronary artery disease.
    HOLLANDER W; CHOBANIAN AV; WILKINS RW
    JAMA; 1960 Sep; 174():5-12. PubMed ID: 13852511
    [No Abstract]   [Full Text] [Related]  

  • 10. [The fraction of the serum cholesterol extracted after adsorption on paper. II. Its relations to coronary atherosclerosis].
    BEAUMONT JL; ANGUERA G; SWYNGHEDAUW B; RICHARD JL
    Rev Atheroscler; 1961; 3():76-82. PubMed ID: 13866210
    [No Abstract]   [Full Text] [Related]  

  • 11. Composition of plasma cholesterol ester in relation to coronary-artery disease and dietary fat.
    LEWIS B
    Lancet; 1958 Jul; 2(7037):71-3. PubMed ID: 13564763
    [No Abstract]   [Full Text] [Related]  

  • 12. [Content of highly unsaturated fatty acids in the blood of patients with coronary atherosclerosis and in experimental hypercholesterinemia].
    KOMAROVA IN
    Vestn Akad Med Nauk SSSR; 1961; 16(3)():27-32. PubMed ID: 13757876
    [No Abstract]   [Full Text] [Related]  

  • 13. Cephalins in the blood. Patients with coronary heart disease and patients with hyperlipemia.
    NOTHMAN MM; PROGER S
    JAMA; 1962 Jan; 179():40-3. PubMed ID: 14480482
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of anticoagulants on the blood lipid level in patients with coronary atherosclerosis].
    MIASNIKOV LA; PIATENKO VI
    Sov Med; 1961 Jul; 25():31-5. PubMed ID: 13770122
    [No Abstract]   [Full Text] [Related]  

  • 15. The plasma lipids in coronary artery disease.
    OLIVER MF; BOYD GS
    Br Heart J; 1953 Oct; 15(4):387-92. PubMed ID: 13093872
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of serum cholesterol and lipid phosphorus in coronary heart disease.
    GUPTA KK; IYER PV; NATH HP
    Metabolism; 1958 Jul; 7(4 Pt 1):349-54. PubMed ID: 13565388
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIET, HYPERCHOLESTEROLAEMIA AND CORONARY HEART DISEASE.
    BLACKET RB; WOODHILL J; MISHKEL MA
    Med J Aust; 1965 Jan; 1(3):59-63. PubMed ID: 14265215
    [No Abstract]   [Full Text] [Related]  

  • 19. The extractability of serum lipids in normal subjects, coronary disease, hyperlipemia, and hypercholesteremia.
    AMATUZIO DS; GRANDE F; WADA S
    Circulation; 1962 Mar; 25():540-4. PubMed ID: 13860890
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum magnesium-cholesterol relationships in the Central Australian aborigine and in Europeans with and without ischaemic heart disease.
    CHARNOCK JS; CASLEY-SMITH J; SCHWARTZ CJ
    Aust J Exp Biol Med Sci; 1959 Dec; 37():509-16. PubMed ID: 13809346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.